Pulse Biosciences (PLSE) logo

Pulse Biosciences (PLSE) stock

Bioelectric medicine , market cap $4.0B

$52.90
+1.26%

As of Monday's close · Live for Pro members at the open

Quality Score
9
Average
In its industry
#23of 85

PLSE's Quality Score rose 1 point on Mon, Nov 2, to 9. Trading was quieter than usual.

See PLSE's 14 chart checksSee it live, free until Wednesday morning. No account. No card. Then keep going with a free account.

We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.

Why is PLSE up?

Up 209% in a year while the S&P 500 rose 12%.

  • Its filed figures weakened while the shares beat the market.

Sources: Price history, Oct 30, 2026; Annual reports, Dec 31, 2025

1 more reason, free with an account →The other side and the timeline, for Pro members.

Key facts on PLSE

Key facts on PLSE
The chartStronger than 99% of stocks above every average
Latest filing424B5, Sep 15 Set up an at-the-market program for up to $85M of shares, about 2% of its market value
1 more reason behind PLSE's 9, free with an account →3 more reasons behind PLSE's 9, for Pro members.

PLSE in the news

ReportReports Thursday, after the close. Every 3 months, a company tells everyone how much it sold and earned. It fell after 3 of its last 4 reports, -2.7% on average. Past reports ›

What's next

Thu Nov 12: Stifel Healthcare Conference 2026Investor conference · date confirmed.

PLSE catalysts

Coming up

After its last 4 reports it closed -2.7% on average, higher 1 of 4 times.

Why PLSE scores 9

Averagefor quality, not price, 6 of 14 chart checks firingWhat the Quality Score means

  • +6Chart checks 6 of 14 firing right now, one point each
  • +4Long-term trend above a rising 200-⁠day average, near its 52-⁠week high, at a multi-⁠year high
  • Run-up adds
  • Profit subtractsRead on the last four quarters against the four before, or the last full year where no quarters are filed.
  • Volatility subtractsA daily range of 5% or more with nothing behind it (no profit or cash flow, sales shrinking, or 10% more shares outstanding with no free cash flow): -1, or -2 from 8%.
  • Cash flow subtracts-1 when free cash flow over the last four quarters is negative.

No effect today: Size, Growth, Dilution, Persistence, News, and Insider trades.

What every line is worth, and the reason behind it, on PLSE and every other stock.Get in free →

Price, score, chart checks, and the industry rank are from a snapshot taken at 9:36 PM ET, at least 15 minutes behind. How we rank stocks.

Tested. Our top-⁠scored stocks returned 2.2x the average stock over the next month. How we tested it

Alert me when PLSE's Quality Score turns up

See it live, free until Wednesday morning. No account. No card. Then keep going with a free account.

Here is what Pro members see.

  • The same page for Pro members, on AMD

    Its Quality Score and rank, the line that drives it, and the live price.

  • The full chart

    A year of candles to start, out to the whole history, with insider trades marked and the Quality Score under the price.

  • Every line of the score

    Price action, the company, and signals, each with its points, on PLSE and every other stock.

  • CEOs buying their own stock

    Every CEO buy, biggest names first. Sort, filter, save the list, and set optional alerts.

  • Congress trades

    A member's trades, newest first, each with its amount. Sort and filter the whole list.

  • 14 chart checks, read for you

    The ones firing on the stock, each in plain words, its rule a tap away.

  • Earnings, week by week

    Who reports each day, and how each stock took its last four reports.

  • FDA dates, counted down

    Each date in the company's words, its cash against the date, and an optional alert before it.

  • The market map

    Every stock a box, colored by its Quality Score.

  • Themes, ranked live

    Each theme's stocks ranked by Quality Score, live. Here, AI chips.

  • The top 10, every day

    The ten highest Quality Scores at each close, kept day by day, week by week.

  • Optional alerts, your way

    Pick a stock, a score, a price, a filing, or a whole scan. It tells you by push or email.

  • Your watchlist, scored

    Your stocks by Quality Score, today's move, or name.

  • On your phone and your laptop

    The same account and watchlist on both, each laid out for its screen.

  • Prices refresh every 2.5 seconds during market hours.
  • Optional alerts by push, email, or the bell.
  • Add it to your Home Screen and it opens like an app.

PLSE has 6 of 14 chart checks firing

Volume1 of 3 shown
Tight range1 of 3 shown
Buying1 of 3 shown
The other 10 checks on PLSE, and all 14 on every stock.Get in free →

PLSE RSI today: 54.6, above its 50-day and 200-day averages

Not scored

Not in the Quality Score: over 20 years of tests, 2006 to 2026, they added no edge.

The deep dive on PLSE

  • What it does and how it makes money3 findings"The vast majority of our granted patents have an expiration date between 2035 and 2042." (10-K for fiscal 2025)SEC filing · Feb 19, 2026
  • Where it stands3 findings3 offerings of shares or notes since Feb 2026, $220M in all.SEC filing · Sep 15, 2026
  • What changed in its filings1 findingA new heading in its "Risk Factors" this year: "Implementation of artificial intelligence and machine learning technologies may result in legal and regulatory risks, reputational harm, or other adverse consequences to our business." (10-K for fiscal 2025; not in fiscal 2024's)SEC filing · Feb 19, 2026, against the one of Mar 31, 2025
  • Who holds and trades it2 findingsFor Pro members2 findings on who holds and trades PLSE, for Pro members
6 more findings on PLSE, each with its source, for Pro membersGet in free →

How PLSE ranks in Medical Devices

PLSE is #23 of 85 by Quality Score.

How PLSE ranks in Medical Devices
23Pulse Biosciences (PLSE) logoPLSEPulse Biosciences9

More in Medical Devices

When does PLSE report earnings, and what happens after?

Reports Thu Nov 5, after the close (in 3 days). Confirmed.

What an earnings report is: every 3 months, a company tells everyone how much it sold and earned. We read the figures, the outlook, and how the stock moved after.

ReportedGapReaction5
sessions
Aug 6, 2026After close-1.1%+10.9%+17.5%
May 4, 2026Before open-1.6%-3.8%-8.4%
Feb 19, 2026After close-2.5%-14.6%-23.1%

PLSE closed higher after 1 of its last 4 reports.

All 4 reports, and PLSE's Quality Score going into each

Everyone reporting earnings this week

PLSE sales and profit by year

Sales and profit by year

Sales grew in two of the last five years, to $350K in 2025. It lost money in each of the six years.

PLSE share count over time

Shares: 2.9% more than a year ago (to Jun 30).

Shares of PLSE outstanding, as filed
Shares
outstanding
As
of
71.3MJul 31, 2026
69.2MMay 12, 2026
68.2MMar 31, 2026
68MFeb 13, 2026
Offerings, shelves, and splits of PLSE, from its filings
From its
filings
Filed
Set up an at-the-market program for up to $85M of shares, about 2% of its market valueSep 15, 2026
Set up an at-the-market program for up to $75M of shares, about 2% of its market valueAug 6, 2026
Set up an at-the-market program for up to $60M of shares, about 2% of its market valueFeb 19, 2026

Insiders trading PLSE

PLSE insider trades

3 insiders bought $13.5M across 6 filings in the last 6 months. No open-⁠market sales on record. The newest:

BuyLiane Rae Teplitsky$50KChief Operating Officerat $49.95 on Sep 1, filed Sep 2
All 6 insider filings on PLSE from the last six months, for Pro members.Get in free →

All PLSE insider trades

PLSE's officers and directors

Officers and directors with a Form 4 in the last 12 months.

See insider trades by person

Which ETFs hold PLSE?

In ETFs: PLSE is under 0.1% of VTI, the most of the 24 funds Breakaway covers, by their holdings as filed for Jun 30, 2026.

About Pulse Biosciences

Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed Field Ablation (nsPFA) technology delivers nanosecond pulses of electrical energy to nonthermally clear cells while sparing adjacent noncellular tissue.

116 employeesHayward, CApulsebiosciences.com

What Pulse Biosciences says it competes with

“Our medical products and products under development are for applications that are constantly under pressure from intense competition from rapidly evolving companies and new scientific discoveries.”

From its annual report, SEC filing · Feb 19, 2026

1 more sentence and what it says it does, for Pro membersGet in free →

PLSE's score card

Pulse Biosciences (PLSE): Quality Score 9, Average, #23 of 85 in Medical Devices, with its price, on Breakaway
The picture a link to this page shows when it is shared.

Pro members see every line of every stock's score.

  • What would move PLSE's score: 5 things
  • 6 more filings explained, a plain line each
  • Real-⁠time prices, no delay
BreakawaySep 2Liane Rae Teplitsky bought PLSE$50K at $49.95, filed Sep 2

Alerts are optional.

See PLSE's 14 chart checks

See it live, free until Wednesday morning. No account. No card. Then keep going with a free account.

Straight Answers

As of Nov 2, 2026: PLSE's Quality Score is 9 (Average), #23 of 85 in Medical Devices. Insiders bought $13.5M in the last 6 months (Form 4).

Is PLSE a good stock to buy? What its Quality Score says

PLSE scores 9 today, which Breakaway calls Average. It is #23 of 85 in Medical Devices by Quality Score, with 6 of 14 chart checks firing. Up 209% in a year while the S&P 500 rose 12%. Breakaway does not say whether to buy any stock: the score does not know your situation, and it is not a recommendation to buy or sell anything. Please do your own research.

What is PLSE's Quality Score?

PLSE scores 9 today, which Breakaway calls Average (6 to 10). That is #23 of 85 in Medical Devices by Quality Score. The score adds up the chart checks, the trend, the company's filed sales, its profits, the news, insider trades, and Congress trades. The section above lists the lines behind PLSE's 9.

Are insiders buying PLSE?

3 insiders bought $13.5M across 6 filings in the last 6 months. No open-⁠market sales on record. The newest is Liane Rae Teplitsky, Chief Operating Officer, who bought $50K on Sep 1. Every filing, with the scored weight, for Pro members.

Are the prices delayed?

Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.

The moves after past earnings reports are past behavior, not a forecast.

The price, the score, the chart checks and readings, and the industry rank on this page are delayed at least 15 minutes.

Our top-scored stocks' record: Oct 2021 to Sep 2026, before costs. Recorded live since Sep 9 2026.

Breakaway publishes impersonal securities research and analytical tools: one formula, the same score for everyone. It is not personalized investment advice, and nothing here is a recommendation to buy or sell any security.

Market data from a licensed vendor. The age of every quote is shown on the page.

This browser is too old to show this page right. Update it, or open this page in Safari or Chrome.